← Browse by Condition
Medical Condition

st segment elevation myocardial infarction stemi

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 3

ClinicalMetric tracks all active clinical trials for st segment elevation myocardial infarction stemi sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3
1
Phase 4
1
Top Sponsors
Kindai University 1 trial
RenJi Hospital 1 trial
Ain Shams University 1 trial
German Diabetes Center 1 trial
NCT05709626 Phase 4
Recruiting

PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

Enrollment
2,258 pts
Location
Japan
Sponsor
Kindai University
View Trial →
NCT06385834
Recruiting

The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction

Enrollment
201 pts
Location
China
Sponsor
RenJi Hospital
View Trial →
NCT06847568 Phase 3
Recruiting

The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow

Enrollment
1,000 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →
NCT05046483
Recruiting

Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI

Enrollment
300 pts
Location
Germany
Sponsor
German Diabetes Center
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology